Verici Dx plc (LON:VRCI – Get Free Report)’s stock price shot up 7.2% during trading on Tuesday . Verici Dx Trading Up 16.7%The company has a market capitalization of £10.59 million, a PE ratio of -28.00 and a beta of 1.59. The business has a fifty day moving average price of GBX 0.55 and a 200 day moving average price of GBX 1.19. Verici Dx Company Profile(Get Free Report)Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. Featured ArticlesReceive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.